Florian Doepp Wasiem Sanad Stephan J Schreiber Gert Baumann Adrian C Borges
10.1186/1476-7120-3-14
Cardiovasc Ultrasound
2005 May 26;3:14.
CC BY
https://pubmed.ncbi.nlm.nih.gov/15918893/
Heparin / administration & dosage Thrombolytic Therapy / adverse effects Thrombosis / chemically induced Thrombosis / prevention & control Tissue Plasminogen Activator / adverse effects Ventricular Dysfunction, Left / chemically induced Ventricular Dysfunction, Left / prevention & control
Heparin / administration & dosage Thrombolytic Therapy / adverse effects Thrombosis / chemically induced Thrombosis / prevention & control Tissue Plasminogen Activator / adverse effects Ventricular Dysfunction, Left / chemically induced Ventricular Dysfunction, Left / prevention & control Acute Disease Brain Ischemia / complications Brain Ischemia / diagnostic imaging Brain Ischemia / drug therapy Fibrinolytic Agents / adverse effects Humans Male Middle Aged Stroke / diagnostic imaging Stroke / drug therapy Stroke / etiology Tissue Plasminogen Activator / therapeutic use Treatment Outcome Ultrasonography Fibrinolytic Agents Heparin Tissue Plasminogen Activator
PMC1156922
15918893
Left ventricular apical thrombus after systemic thrombolysis with recombinant tissue plasminogen activator in a patient with acute ischemic stroke
2005